The development of new drugs against tuberculosis and diphtheria is focused on disrupting the biogenesis of the cell wall, the unique architecture of which confers resistance against current therapies. The enzymatic pathways involved in the synthesis of the cell wall by these pathogens are well unde...
ORGANISM(S): Escherichia coli Corynebacterium glutamicum Corynebacterium glutamicum ATCC 13032 Bacillus subtilis subsp. subtilis str. 168 Gluconobacter oxydans